Zenas Biopharma (ZBIO) Stock
Zenas Biopharma (ZBIO) closed at $27.75 on Nov 17, 2026; its Tenet Score is 29 of 100 against 340 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $27.75
- Nov 17, 2026
- Market cap
- $1.8B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 13.50 – 44.60
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 29/100
- Weak · 340 Healthcare peers
Industry: Pharmaceutical Preparations
Zenas Biopharma Inc. scores 29/100. Weak. Quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 29 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ✕ Reversal Evidence
- ✕ Quality Floor
13F flows & insider trades land here.
We are a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. With the evolving understanding of the pathogenesis of autoimmun…
Similar-sized companies in Pharmaceutical Preparations
The 8 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| MBX Biosciences Inc.MBX | 53 | $2.6B |
| Septerna Inc.SEPN | 54 | $2.0B |
| Rapport Therapeutics Inc.RAPP | 59 | $1.5B |
| Alto Neuroscience Inc.ANRO | 53 | $1.1B |
| Alumis Inc.ALMS | 56 | $667.3M |
| Bicara Therapeutics Inc.BCAX | 61 | $666.7M |
| ArriVent BioPharma Inc.AVBP | 69 | $572.5M |
| BioAge Labs Inc.BIOA | 74 | $239.7M |
Common questions
What sector and industry is Zenas Biopharma in?
Zenas Biopharma is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Zenas Biopharma's Tenet Score?
Zenas Biopharma's Tenet Score is 29 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




